This is a federal contract award from the Department of Veterans Affairs (VA) to Galderma Laboratories, L.P., a foreign-owned, for-profit pharmaceutical manufacturer. The $12,314.40 firm fixed-price delivery order is for the emergency procurement of NEMOLIZUMAB CCP 30MG INJ, a specialized injectable medication, to support the VA's Veterans Integrated Service Network 9 (VISN 9). The contract is a task order issued under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), and does not have a set-aside designation. Galderma Laboratories, L.P. appears to be a key supplier of injectable pharmaceutical products to various VA regional networks based on the multiple recent contract awards for similar products.
Generated 3/11/25, 9:42 AM